. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: RSC Adv. 2014 Apr 8;4(34):17959–17968. doi: 10.1039/C4RA01112K

Table 2.

Quantitative IR820 organ content 24 hours after i.v. injection of IR820-PGMD NPs, IR820 or DOX-IR820-PGMD NPs.

24h organ and plasma IR820 dye content (n=3)	Liver (μg/g)	Lungs (μg/g)	Intestines (μg/g)	Kidneys (μg/g)	Plasma (μg/mL)
IR820-PGMD NPs	0.21±0.09	0.23±0.07	0.07±0.02	0.25±0.09	^*0.18±0.04
IR820	0.21±0.11	0.28±0.03	0.05±0.006	0.41±0.11	0.10±0.003
DOX-IR820-PGMD NPs	0.08±0.01	0.26±0.08	0.05±0.02	^*0.21±0.04	^*0.26±0.06

Values represent average±SD.

P<0.05, significant difference between free IR820 and NP dye content in kidneys and plasma.